Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Adagene Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +8 vs. Q4 2025
- Shares held
- 3.30M
- +210.8K (+6.8%) vs. Q4 2025
- Total value
- $9.70M
- +$3.67M (+60.9%) vs. Q4 2025
- New holders
- 11
- 3 more added
- Sold out
- 3
- 6 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADAG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $81.0M |
| Q1 2026 | 25 | $9.70M |
| Q4 2025 | 17 | $6.03M |
| Q3 2025 | 17 | $11.3M |
| Q2 2025 | 15 | $11.8M |
| Q1 2025 | 14 | $11.6M |
| Q4 2024 | 15 | $20.3M |
| Q3 2024 | 13 | $25.3M |
| Q2 2024 | 14 | $33.7M |
| Q1 2024 | 17 | $34.3M |
| Q4 2023 | 11 | $15.5M |
| Q3 2023 | 10 | $6.16M |
| Q2 2023 | 10 | $6.02M |
| Q1 2023 | 11 | $6.02M |
| Q4 2022 | 9 | $5.58M |
| Q3 2022 | 11 | $7.60M |
| Q2 2022 | 15 | $15.4M |
| Q1 2022 | 15 | $29.7M |
| Q4 2021 | 16 | $67.3M |
| Q3 2021 | 19 | $126.6M |
| Q2 2021 | 16 | $80.5M |
| Q1 2021 | 27 | $115.5M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Adagene Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Exome Asset Management LLC | 736,845 | $2.89M | 1.70% | −323,376−30.5% | Reduced |
| Ameriprise Financial Inc | 607,903 | $2.38M | 0.00% | +607,903 | New |
| SC China Holding Ltd | 1,343,364 | $2.03M | 0.13% | 00.0% | Unchanged |
| Mill Creek Capital Advisors, LLC | 199,610 | $782.5K | 0.02% | 00.0% | Unchanged |
| Morgan Stanley | 66,148 | $259.3K | 0.00% | −9,497−12.6% | Reduced |
| Invesco Ltd. | 47,124 | $184.7K | 0.00% | +47,124 | New |
| SmartHarvest Portfolios, LLC | 40,312 | $158.0K | 0.07% | +1,541+4.0% | Added |
| Kamunting Street Capital Management, L.P. | 38,070 | $149.0K | 0.08% | −87,962−69.8% | Reduced |
| Persistent Asset Partners Ltd | 35,126 | $137.7K | 0.05% | +35,126 | New |
| Dauntless Investment Group, LLC | 34,775 | $136.3K | 0.38% | +34,775 | New |
| Renaissance Technologies LLC | 34,533 | $135.4K | 0.00% | +34,533 | New |
| Jane Street Group, LLC | 30,425 | $119.3K | 0.00% | +30,425 | New |
| Alyeska Investment Group, L.P. | 20,710 | $81.2K | 0.00% | +20,710 | New |
| Royal Bank of Canada | 16,850 | $66.0K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 14,710 | $57.7K | 0.00% | −3,290−18.3% | Reduced |
| Quadrature Capital Ltd | 11,617 | $45.5K | 0.00% | +11,617 | New |
| Geode Capital Management, LLC | 10,309 | $40.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,002 | $15.7K | 0.00% | +1,449+56.8% | Added |
| BNP Paribas Arbitrage, SA | 3,700 | $14.5K | 0.00% | +2,000+117.6% | Added |
| EverSource Wealth Advisors, LLC | 2,473 | $9.69K | 0.00% | −5−0.2% | Reduced |
| JPMorgan Chase & Co | 712 | $2.70K | 0.00% | +712 | New |
| BlackRock, Inc. | 635 | $2.49K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 400 | $1.57K | 0.00% | +400 | New |
| SBI Securities Co., Ltd. | 69 | $270 | 0.00% | −33−32.4% | Reduced |
| Caitong International Asset Management Co., Ltd | 28 | $110 | 0.00% | +28 | New |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −145,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −48,385−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −12−100.0% | Sold out |